XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
255 hedge funds and large institutions have $7.3B invested in Acceleron Pharma in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 83 increasing their positions, 91 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 91
25% less call options, than puts
Call options by funds: $33.7M | Put options by funds: $44.8M
Holders
255
Holding in Top 10
8
Calls
$33.7M
Puts
$44.8M
Top Buyers
| 1 | +$197M | |
| 2 | +$76.8M | |
| 3 | +$38.1M | |
| 4 |
EP
Eversept Partners
New York
|
+$32.8M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$26.2M |
Top Sellers
| 1 | -$129M | |
| 2 | -$61.2M | |
| 3 | -$38.8M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$38.3M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$29.2M |